Search clinical trials for: Diphtheria Antitoxin

Total 246 results

PT Bio Farma

Completed

Post Marketing Surveillance of Diphtheria Antitoxin (DAT)

Safety Issues

Indonesia
Emergent BioSolutions
Centers for Disease Control and Prevention; Biomedical Advanced Research and...

Completed

BT-010 Registry for the Evaluation of Safety and Clinical Outcomes in Patients Treated With Botulinum Antitoxin

Botulism
Emergent BioSolutions
Department of Health and Human Services

Completed

Botulism Antitoxin Effects on Paralysis Induced by Botulinum Neurotoxins in the EDB Muscle

Healthy Volunteers

United States
Emergent BioSolutions
Department of Health and Human Services

Completed

Safety Study of 7 Botulinum Antitoxin Serotypes Derived From Horses

Healthy

United States
Rajavithi Hospital
Rajavithi Biomolecular Research Center

Completed

Botulism Outbreak in Thailand (Episode II)

Botulism

Thailand
Rajavithi Hospital
Rajavithi Biomolecular Research Center

Completed

Treatment of Survivors After Botulism Outbreak

Respiratory Failure | Botulism

Thailand
Oxford University Clinical Research Unit, Vietnam
Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam

Completed

Intrathecal Tetanus Immunoglobulin to Treat Tetanus (ITITTT)

Tetanus

Vietnam
Apimeds, Inc.

Completed

Apitox, Honeybee Venom Treatment for Osteoarthritis Pain and Inflammation (HBV)

Osteoarthritis of the Knee

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age

Pertussis | Tetanus | Diphtheria | Meningitis | Meningococcal Infection | Haemophilus Influenzae Serotype b (Hib)

United States, Puerto Rico
CanSino Biologics Inc.
Henan Center for Disease Control and Prevention

Completed

Phase I Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed . (PCTDTcP)

Pertussis | Tetanus | Diphtheria

China
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose

Pertussis | Whooping Cough | Tetanus | Diphtheria

United States, Canada
GlaxoSmithKline

Completed

Study to Assess the Safety & Reactogenicity of GSK Biologicals' DTPa/Hib Vaccine When Given at 3, 4 and 5 Months of Age

Tetanus | Diphtheria | Acellular Pertussis | Haemophilus Influenzae Type b

China
Medical University of Warsaw
Medical University of Silesia; Poznan University of Medical Sciences; Wroclaw...

Completed

Diphtheria Vaccination in Adolescents With Inflammatory Bowel Disease

Diphtheria | Inflammatory Bowel Diseases
Sanofi Pasteur, a Sanofi Company

Completed

Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine

Pertussis | Tetanus | Diphtheria | Meningitis | Meningococcemia

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects

Pertussis | Whooping Cough | Tetanus | Diphtheria

United States
Sanofi

Completed

A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older

Pertussis | Tetanus | Diphtheria

United States
Biomat USA, Inc.
Axio Research. LLC; Hammond Clinical Trial Consulting, LLC

Completed

Safety and Efficacy of Two Tetanus-Diphtheria Vaccines for a Donor Hyper Immunization Program

Healthy

United States
GlaxoSmithKline

Completed

Assessment of GSK Biologicals' Tdap Candidate Vaccine Administered as a Booster (6th Dose) in Terms of Immunogenicity and Safety to Children and Adolescents Previously Vaccinated With Five Doses of an Acellular Pertussis-containing Vaccine.

Tetanus | Diphtheria | Acellular Pertussis

Germany
Scott Halperin
Sanofi Pasteur, a Sanofi Company; IWK Health Centre

Completed

Pertussis Maternal Immunization Study

Pregnant Women

Canada
National Institute of Allergy and Infectious Diseases...
Istituto Superiore di Sanità

Completed

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines

Pertussis
Sanofi

Completed

Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX®

Pertussis | Tetanus | Diphtheria

United States
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems

HIV Infections

United States, Puerto Rico
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age

Pertussis | Tetanus | Diphtheria

United States, Canada
Sanofi Pasteur, a Sanofi Company

Completed

Sanofi Pasteur's Tdap Combined Vaccine as a Booster Versus Local DT Vaccine in Children or Versus Local Td Vaccine in Adolescents and Adults in China.

Pertussis | Tetanus | Diphtheria

China
Sanofi

Completed

Immunogenicity and Safety of Pentaxim in South African Infants

Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Infections

South Africa
GlaxoSmithKline

Terminated

Immuno & Safety Study With 2 Formulations of DTPw-HBV/HIB When Given at Birth With Hepatitis B at 2, 4 and 6 Mths.Age.

Hepatitis B | Tetanus | Diphtheria | Haemophilus Influenzae Type b | Whole Cell Pertussis

Dominican Republic
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of Menactra® Vaccine in Subjects Aged 9 to 23 Months in India and in the Russian Federation

Meningitis | Meningococcal Infection

Russian Federation, India
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older

Pertussis | Tetanus | Diphtheria | Poliomyelitis

France, Germany
GlaxoSmithKline

Completed

A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine

Tetanus | Diphtheria | Acellular Pertussis

United States
Sanofi Pasteur, a Sanofi Company

Completed

Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE

Tetanus | Diphtheria | Poliomyelitis

France
Green Cross Corporation

Completed

To Evaluate the Effectiveness(Immunogeneicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Adults

Bacterial Infections

Korea, Republic of
GlaxoSmithKline

Completed

Post-marketing Safety Study of GSK Biologicals' Boostrix® Vaccine

Tetanus | Diphtheria | Acellular Pertussis

United States
Sanofi

Completed

Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months

Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type b

China
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

Recruiting

Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants

Healthy Volunteers

China
Sanofi Pasteur, a Sanofi Company

Completed

A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers

Measles | Rubella | Mumps | Varicella | Meningococcal Meningitis

United States
Sanofi Pasteur, a Sanofi Company

Completed

Persistence of Antibodies in Adolescents and Adults 15 to 23 Years Who Received One Dose of Menactra® or Menomune®

Meningitis | Meningococcal Infection

United States
Sanofi Pasteur, a Sanofi Company

Completed

Antibody Persistence and Booster Dose Response in Subjects Who Received Menactra® Three Years Earlier in Study MTA26

Meningitis | Meningococcemia

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Booster Dose of Meningococcal Diphtheria Toxoid Conjugate Vaccine in Adolescents

Meningitis | Meningococcemia

United States
Sanofi Pasteur, a Sanofi Company

Completed

Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACEL™ Vaccine

Pertussis

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine

Pneumococcal Infection

United States
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.

Active, not recruiting

A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTaP)

Whooping Cough | Tetanus | Diphtheria

China
Sanofi Pasteur, a Sanofi Company

Terminated

Antibody Responses Following Meningococcal Tetravalent (A, C, Y, and W-135) Conjugate Vaccination in Healthy Adults

Meningitis | Meningococcemia

United Kingdom
Sanofi Pasteur, a Sanofi Company

Completed

Dose Comparison Study of Menactra® in US Children

Meningitis | Meningococcal Infection | Neisseria Meningitidis

United States
Sanofi Pasteur, a Sanofi Company

Completed

Post-Marketing Safety Study of Menactra® in Healthy Children, Adolescents, and Adults in the Philippines

Meningitis | Meningococcal Disease

Philippines
Sanofi Pasteur, a Sanofi Company

Completed

Assessment of the Reactogenicity of ADACEL® (TdcP Vaccine) in Children and Adolescents 7 to 19 Years of Age

Pertussis | Diphtheria

Canada
Sanofi

Completed

Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand

Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Infections

Thailand
Sanofi Pasteur, a Sanofi Company

Completed

Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine

Pertussis | Tetanus | Diphtheria

United States, Canada
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Single Dose of Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (SP284) in Japanese Subjects

Meningitis | Meningococcal Infections | Meningococcal Meningitis

Japan
CanSino Biologics Inc.

Active, not recruiting

A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP)

Diphtheria, Tetanus and Acellular Pertussis

China
Sanofi Pasteur, a Sanofi Company

Completed

Study of SP306 Given Intramuscularly Compared to DT Given Subcutaneously in Japanese Adolescents 11 - 12 Years Old

Pertussis | Tetanus | Diphtheria

Japan

Search clinical trials for: Diphtheria Antitoxin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations